Schedule 13G
SLNOEUR Schedule 13G filing by State Street
State Street reported beneficial ownership of 2.7M shares, representing 12% of SOLENO THERAPEUTICS INC in this filing.
FiledMay 12, 2026
Ownership dateMar 31, 2026
Reported shares2.7M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
2.5M
Shared voting power
2.5M
Sole dispositive power
2.7M
Shared dispositive power
2.7M
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- State Street
- CIK
- CIK0000093751
- Accession
- 0000093751-26-000292
- Form
- Schedule 13G
Read the filing in context